People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ONDINE BIOPHARMA Corp | — | Biotechnology | Pre-Seed | $719K | $13.2M | 2009 |
Nicholas Loebel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Loebel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Crane | 1 | 3 |
| William Harper | 1 | 2 |
| Merrill Biel | 1 | 2 |
| Thomas Dawson | 1 | 1 |
| Carolyn Cross | 1 | 1 |
| Margaret Shaw | 1 | 1 |
| Nicolas Loebel | 1 | 1 |
| Colin Watt | 1 | 1 |
| Terence Holland | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.